Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE
about
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersFGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerCellular characterization of epidermal growth factor-expanded free-floating neurospheresA functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North IndiaCommon low-penetrance risk variants associated with breast cancer in Polish women.The FGF/FGFR axis as a therapeutic target in breast cancer.Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancerChallenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transductionTNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death.Breast cancer genome-wide association studies: there is strength in numbers.Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer.Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer.Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.Identifying differentially expressed genes in cancer patients using a non-parameter Ising model.FGFR2 mutant receptor activationSignaling by FGFR2 amplification mutantsGenetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population.
P2860
Q26998955-A7F91A66-AF5A-4875-8E1C-5B47CBB1EE0AQ27851554-D9702E73-F065-4800-B66F-DDA7B8B50F2CQ28219188-60CEA2E7-D341-4AC1-BC91-5AE52A428C0BQ30999913-166A642F-E523-4292-A213-C0C31B32B702Q33332300-30AEF544-B308-4AD7-9922-FC5ACADF39DCQ33780945-30BE578A-F1A7-4450-8D81-6A1343649D8EQ33816374-62E9D513-CAA8-4EA8-AE62-ED8F3735408DQ34379582-EC79D21C-28E1-4347-8231-3DC2ABD9BAE8Q34493797-FE6688FB-389E-48F5-AB06-40CD9336EE38Q34495216-D377A580-AC6C-4AF7-B8B9-B4B6361F851BQ34525011-4C0A2020-8F0E-4698-9EC8-A2BE0F1FD2BEQ35713603-57727A05-12EE-4D9C-9BAC-6DBD5CFF761BQ36245320-FBD74578-B768-4497-AECB-B92B33EC0739Q36321043-B5EC136C-2404-4DB9-AFCC-C205E2CFB48AQ36611618-6BBB5DA9-667C-478A-BF66-37F3ADA7D2C3Q36900522-C4F96346-23AE-4967-97B4-2A1E6CD52565Q36954415-7A3C9523-65E8-4CAD-831F-64E1ABE91D23Q37139660-64D0E714-88E7-4446-A0CA-33F8B14528DFQ37235167-E8177756-C53A-4D2A-B881-E97482B63503Q37332435-9302A669-1137-436A-89CE-1AAC11B5A137Q37392664-E7AE26C3-7531-4348-9123-B82A963E39A7Q37945448-0BDD3BFC-1D06-48C2-99DE-B54EED5F3D56Q38057660-C1B0B74B-B8CA-406D-AA22-1E2944BBA175Q39142753-AD63CFA8-C597-4EED-933A-9CC19863A257Q39301436-9F2E4494-D779-4331-90D6-95A67775B23CQ39436084-4D756EE9-9A12-4F65-86F5-903FDB91CF03Q39715263-5DF33972-EBF4-428F-87D8-E6A863E42739Q44959102-98378E0F-E367-4E61-9E4E-2084605EFA6EQ45314366-C34EF7D6-D003-4F39-8EA5-4DAC0FC7D9F3Q45314370-086E47EA-262B-4CDE-90D4-A6C1E33EFCFAQ46323110-6328A33D-79E5-4414-863F-D2C29A3468C0Q55074487-807DD69A-9023-465B-9C52-FB801A02B801
P2860
Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@ast
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@en
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@nl
type
label
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@ast
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@en
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@nl
prefLabel
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@ast
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@en
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@nl
P2093
P2860
P3181
P356
P1476
Characterization of fibroblast ...... east cancer cell line SUM-52PE
@en
P2093
A Rehemtulla
S L Tannheimer
S P Ethier
P2860
P2888
P304
P3181
P356
10.1186/BCR73
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1049899410